About: Next generation biotech company
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug Tiprelestat.
5 Facts about tiakis
Located in Kiel in the north of Germany
More than 20 years of experience
Lead by a dynamic and multi-disciplinary team
Trusted by renowned partners all over the world
Selected as a partner in federal and state driven R&D programs
“Incorporated in 2000 with full focus on its novel therapy approach“
Our Values: Driven by the vision to improve human health
We seek to shift the treatment paradigm towards a preventive approach that alleviates the suffering and morbidity of most patients undergoing highly invasive surgery by protecting them from inflammatory organ damage and failure.